Based on these findings, the role of PPAR(α) in bile acid detoxification, specifically in regulating the phase II metabolic pathway of bile acid glucuronidation, has emerged as an area of therapeutic interest to improve the treatment of cholestatic liver diseases. Here, PPARA is linked to Cholestatic liver disease.